SAT0388 Long-Term Efficacy and Tolerability of Golimumab in Active Nonradiographic Axial Spondyloarthritis: Results of The Open-Label Extension of A Randomized, Double-Blind Study

D Van Der Heijde,S Huyck,J Braun,G Bergman,J Sieper,M Dougados,A Tzontcheva,W.P Maksymowych,S.P Curtis,G Philip

doi:10.1136/annrheumdis-2016-eular.3011

SAT0388 Long-Term Efficacy and Tolerability of Golimumab in Active Nonradiographic Axial Spondyloarthritis: Results of The Open-Label Extension of A Randomized, Double-Blind Study

D Van Der Heijde, S Huyck + Show 8 more

https://doi.org/10.1136/annrheumdis-2016-eular.3011

Copy DOI

Journal: Annals of the Rheumatic Diseases

Publication Date: Jun 1, 2016

Affiliation: Leiden University Medical Center, MSD (United States), Rheumazentrum Ruhrgebiet, Délégation Paris 5, Université Paris Cité

#Open-label Extension #Golimumab + Show 8 more

Abstract
Full-Text
Similar Papers

Abstract

BackgroundThe efficacy and tolerability of golimumab (GLM) for nonradiographic axial spondyloarthritis (nr-axSpA) have been demonstrated in a 16-week randomized, double-blind (DB), placebo (PBO)-controlled, phase 3 study (GO-AHEAD; NCT01453725).1ObjectivesWe report the...

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: Annals of the Rheumatic Diseases

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.